Scorpius Holdings Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
SCPX American 2834 https://www.nighthawkbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Scorpius Holdings Inc

Scorpius Holdings Announces Receipt of Filing Delinquency Notification - Apr 22nd, 2024 9:00 pm
Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University - Mar 19th, 2024 12:30 pm
Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium - Mar 14th, 2024 12:30 pm
Scorpius Holdings, Inc. Announces Closing of Public Offering - Mar 12th, 2024 9:00 pm
SCPX: Sharply Positive Growth - Mar 11th, 2024 10:42 am
Scorpius Holdings, Inc. Announces Pricing of Public Offering - Mar 8th, 2024 5:20 am
Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock - Mar 7th, 2024 9:18 pm
Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023 - Mar 7th, 2024 1:30 pm
NightHawk Biosciences Completes Name Change to Scorpius Holdings; Trading to Commence Under “SCPX” Effective at the Market Open Today - Feb 6th, 2024 1:00 pm